Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
I-Shu Lee has a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is currently 1 pending office action for this entity. This action is assigned to 1 distinct examiner and 1 distinct art unit. The presence of 1 distinct art unit indicates that the current Biotechnology & Pharmaceuticals research is being reviewed by 1 specialized group at the USPTO.
PRIEST, JESSICA MARIE is the busiest examiner for the portfolio, currently managing 1 pending office action. The involvement of 1 distinct examiner and 1 distinct art unit shows that the current pending matters are concentrated in 1 area of Biotechnology & Pharmaceuticals research. This means that PRIEST, JESSICA MARIE is the sole examiner responsible for the active workload. With 1 pending office action and 1 distinct examiner, the prosecution process is concentrated. This profile allows for interaction with the patent office and affects the management of the pending intellectual property matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PRIEST, JESSICA MARIE | 1 | — | — |
| Art Unit | Apps |
|---|---|
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18520520 | Anti-GM2AP ANTIBODY AND APPLICATIONS THEREOF | PRIEST, JESSICA MARIE | 1642 | §112 | Non-Final OA | — | Pending | Nov 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialI-Shu Lee has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jessica Marie Priest has the most, with 1 of I-Shu Lee's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
